Pioglitazone in Early Parkinson's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tanya Simuni, MD
Northwestern University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Univeristy of Alabama at Birmingham
Birmingham, Alabama, United States
- Barrow Neurological Institute
Phoenix, Arizona, United States
- the Parkinson'S & Movement Disorder Institute
Fountain Valley, California, United States
- University of Southern California
Los Angeles, California, United States
- University of California San Fransisco
San Francisco, California, United States
- Univeristy of Colorado Denver
Aurora, Colorado, United States
- University of Florida
Gainsville, Florida, United States
- University of Florida, Jacksonville
Jacksonville, Florida, United States
- University of Miami
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Medical College of Georgia
Augusta, Georgia, United States
- Pacific Health Research & Education Institute
Honolulu, Hawaii, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Lsu Health Science Center Shreveport
Shreveport, Louisiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Michigan State University
East Lansing, Michigan, United States
- Struthers Parkinson'S Center
Golden Valley, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- North Shore - Lij Health System
Manhasset, New York, United States
- Duke University
Durham, North Carolina, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Vermont
Burlington, Vermont, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 31 May 2014
- Completion
- 31 May 2014
- Last update posted
- 14 Oct 2015
- Registered enrollment
- 210
- Registry id
- NCT01280123
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.